or buy their stock, anybody knows their stock symbol and what exchange it is 
traded at.


----- Original Message ----- 
From: "Kathleen Cochran" <[log in to unmask]>
To: <[log in to unmask]>
Sent: Monday, July 26, 2010 7:01 AM
Subject: Re: GDNF making a comeback


> Maybe we should all be raising money for Medgenesis.
>
> Kathleen
>
> On 24 July 2010 22:55, [log in to unmask] <[log in to unmask]> wrote:
>
>> Article from the Times Colonist, Victoria, Canada, 7/24/10
>>
>> "Local biotech firm believes it's on the cusp of a brain breakthrough"
>>
>> is about MedGenesis, the Canadain biotech that managed to get the license
>> from Amgen, after 4 years to further develop  GDNF. They are using a
>> convection enhanced delivery system, that  allows the delivery of 
>> treatment
>> via microscopic catheters, inserted through a patient's skull, into 
>> highly
>> specific areas of brain tissue.
>>
>> . The company seems to be commited for GDNF to succeed,.As un-Amgen like 
>> as
>> we could ever hope for.
>>
>> Excerpts:"According to MedGenesis CFO Michael Lincoln, the company is
>> estimating the cost of getting GDNF through the trials and to market 
>> could
>> be anywhere between $65 million and $100 million."Financing is always a 
>> key
>> issue, and it was to our bad luck that the bottom fell out of the world
>> economy at the time we needed to finance operations," said Mohr (CEO), 
>> who
>> noted the company has managed through it because he had significant 
>> personal
>> resources to draw on and a number of well-heeled contacts who bought into
>> their plans.
>> Mohr also pointed out his executive team stuck with the program. He took 
>> no
>> salary for three years and his team worked for cut rates.
>> Mohr said the fact his team remains intact is testament to the belief in
>> what they are doing.
>> "Our entire executive team is still at the table, nobody left," he said.
>> "There is something there."
>> "Mohr is hopeful they can begin Phase 2 clinical trials next year, a
>> process expected to take about two years, including data analysis and
>> dealing with Health Canada and the federal Food and Drug Administration 
>> in
>> the U.S.
>> "We're going to manufacture the product and go back into the clinic next
>> year and we're very hopeful a pathway to success can be found," he said.
>> Read full article
>> http://www.timescolonist.com/health/Local+biotech+firm+believes+cusp+brain+breakthrough/3317850/story.html#ixzz0udpxbHyO
>>
>>
>>
>> --------- Forwarded Message ----------
>> From: "Stan" <[log in to unmask]>
>> To: [log in to unmask]
>> Subject: [pipelinerscore] GDNF "breakthrough" claimed
>> Date: Sat, 24 Jul 2010 18:44:55 -0000
>>
>>
>> http://www.timescolonist.com/health/Local+biotech+firm+believes+cusp+brain+breakthrough/3317850/story.html
>>
>>
>> ------------------------------------
>>
>> Yahoo! Groups Links
>>
>> <*> To visit your group on the web, go to:
>>   http://groups.yahoo.com/group/pipelinerscore/
>>
>> <*> Your email settings:
>>   Individual Email | Traditional
>>
>> <*> To change settings online go to:
>>   http://groups.yahoo.com/group/pipelinerscore/join
>>   (Yahoo! ID required)
>>
>> <*> To change settings via email:
>>   [log in to unmask]
>>   [log in to unmask]
>>
>> <*> To unsubscribe from this group, send an email to:
>>   [log in to unmask]
>>
>> <*> Your use of Yahoo! Groups is subject to:
>>   http://docs.yahoo.com/info/terms/
>>
>>
>> __._,_.___
>>
>> Your email settings: Individual Email|Traditional
>> Change settings via the Web (Yahoo! ID required)
>> Change settings via email: Switch delivery to Daily Digest | Switch to
>> Fully Featured
>> Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
>> __,_._,___
>>
>> ----------------------------------------------------------------------
>> To sign-off Parkinsn send a message to: mailto:
>> [log in to unmask]
>> In the body of the message put: signoff parkinsn
>>
>
> ----------------------------------------------------------------------
> To sign-off Parkinsn send a message to: 
> mailto:[log in to unmask]
> In the body of the message put: signoff parkinsn
> 

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn